NanoNewron, Inc.
PrivateLast Round
Grant
Sep 10, 2025
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NanoNewron, Inc. operates in Healthcare & Life Sciences and is based in Union, New Jersey. Its latest recorded funding round was a Grant round in September 2025.
NanoNewron, Inc. is a biotechnology company that develops humanized biologics designed to cross the blood-brain barrier to treat central nervous system diseases such as Alzheimer's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NanoNewron, Inc. Comparables
Compare NanoNewron, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ossianix | 85% | |
| Lauren Sciences LLC | 83% | |
| Key2Brain | 83% |
For institutional investors. Book with your work email.
NanoNewron, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 10, 2025 | ||||
| Grant | Feb 15, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NanoNewron, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 1150% MoM, reaching 1.8K.
- Sep 10, 2025
$3M grant awarded by the National Institutes of Health.
For institutional investors. Book with your work email.
NanoNewron, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NanoNewron, Inc.'s valuation, stock price, and market status.
Is NanoNewron, Inc. a public or private company?
NanoNewron, Inc. is a private company.
What is the current stock price of NanoNewron, Inc.?
NanoNewron, Inc. is a private company, so its shares have no public market price. Caplight tracks NanoNewron, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NanoNewron, Inc. worth (valuation)?
Valuation information for NanoNewron, Inc. is not publicly available.
Can I buy NanoNewron, Inc. stock?
NanoNewron, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NanoNewron, Inc.'s last funding round?
NanoNewron, Inc.'s most recent funding round was Grant on September 10, 2025.
Who are the main investors in NanoNewron, Inc.?
Key investors in NanoNewron, Inc. include National Institute on Aging, National Institutes of Health (NIH).
Will NanoNewron, Inc. IPO soon?
No public IPO plans have been announced for NanoNewron, Inc..
How can I track NanoNewron, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NanoNewron, Inc.'s shares on secondary markets.